Adaptive Biotechnologies Share Price Today
(NASDAQ: ADPT)

Name: Adaptive Biotechnologies Share Price Today (NASDAQ: ADPT) - Adaptive Biotechnologies Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Adaptive Biotechnologies share price is $7.36 & ₹622.84 as on 2 May 2025, 2.30 'hrs' IST

$7.36

Market is closed - opens 7 PM, 02 May 2025

View live Adaptive Biotechnologies share price in Dollar and Rupees. Guide to invest in Adaptive Biotechnologies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Adaptive Biotechnologies, along with analyst recommendations, forecasts, and comprehensive financials.

Adaptive Biotechnologies share price movements

Today's Low: $7.22
Today's High: $7.50
$7.36
1.97%
Downside
Day's Volatility :3.8%
Upside
1.87%
52 Weeks Low: $2.56
52 Weeks High: $9.01
$7.36
65.22%
Downside
52 Weeks Volatility :71.59%
Upside
18.31%

Adaptive Biotechnologies (ADPT) Returns

Period	Adaptive Biotechnologies Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-5.16%	-4.4%	0.0%
6 Months	38.42%	-5.0%	0.0%
1 Year	150.85%	-0.1%	0.0%
3 Years	-17.88%	8.4%	-6.1%

Adaptive Biotechnologies (ADPT) Key Statistics

in dollars & INR

Previous Close	$7.36
Open	$7.44
Today's High	$7.5
Today's Low	$7.215
Market Capitalization	$1.2B
Today's Volume	$2.0M
52 Week High	$9.01
52 Week Low	$2.56
Revenue TTM	$179.0M
EBITDA	$-136.1M
Earnings Per Share (EPS)	$-1.08
Profit Margin	-89.12%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-62.49%

How to invest in Adaptive Biotechnologies Stock (ADPT) from India?

It is very easy for Indian residents to invest directly in Adaptive Biotechnologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Adaptive Biotechnologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Adaptive Biotechnologies or ADPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Adaptive Biotechnologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Adaptive Biotechnologies shares which would translate to 0.115 fractional shares of Adaptive Biotechnologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Adaptive Biotechnologies, in just a few clicks!

Returns in Adaptive Biotechnologies (ADPT) for Indian investors in Rupees

The Adaptive Biotechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Adaptive Biotechnologies investment value today

Current value as on today

₹2,52,612

Returns

₹1,52,612

(+152.61%)

Returns from Adaptive Biotechnologies Stock

₹1,51,195 (+151.19%)

Dollar Returns

₹1,417 (+1.42%)

Indian investors sentiment towards Adaptive Biotechnologies (ADPT)

Period: Apr 1, 2025 to May 1, 2025. Change in 30 Days versus previous period

Search interest for Adaptive Biotechnologies Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Adaptive Biotechnologies

Viking Global Investors LP
20.19%
Rubric Capital Management LP
9.83%
BlackRock Inc
8.16%
Vanguard Group Inc
7.21%
ARK Investment Management LLC
6.34%
Sumitomo Mitsui Trust Group Inc
4.60%

Analyst Recommendation on Adaptive Biotechnologies

Rating

Trend

Buy

78%Buy

21%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Adaptive Biotechnologies(by analysts ranked 0 to 5 stars)

Analyst Forecast on Adaptive Biotechnologies Stock (ADPT)

What analysts predicted

Upside of 31.99%

Target:

$9.71

Current:

$7.36

Insights on Adaptive Biotechnologies Stock (Ticker Symbol: ADPT)

Price Movement
In the last 7 days, ADPT stock has moved down by -7.0%
Increasing Revenue
Revenue is up for the last 4 quarters, 41.87M → 47.45M (in $), with an average increase of 4.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -32.07M → -33.69M (in $), with an average decrease of 5.1% per quarter
ADPT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 89.3% return, outperforming this stock by 104.4%

Adaptive Biotechnologies Technicals Summary

Sell

Neutral

Buy

Adaptive Biotechnologies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Adaptive Biotechnologies (ADPT) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Adaptive Biotechnologies Corp	-7.43%	38.42%	150.85%	-17.88%	-77.35%
Biontech Se	9.85%	-8.05%	11.13%	-31.31%	123.92%
Regeneron Pharmaceuticals, Inc.	-4.3%	-29.03%	-36.14%	-9.35%	10.5%
Vertex Pharmaceuticals Incorporated	5.32%	8.08%	27.25%	89.22%	92.38%
Alnylam Pharmaceuticals, Inc.	-1.34%	-3.89%	75.14%	84.24%	92.68%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Adaptive Biotechnologies Corp	NA	NA	0.0	-0.92	-0.62	-0.16	NA	1.37
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.38	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Adaptive Biotechnologies Corp	Buy	$1.2B	-77.35%	NA	-89.12%
Biontech Se	Buy	$29.5B	123.92%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	10.5%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$129.4B	92.38%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.3B	92.68%	NA	-12.37%

About Adaptive Biotechnologies

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. It has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Organization	Adaptive Biotechnologies
Employees	619
CEO	Mr. Chad M. Robins M.B.A.
Industry	Commercial Services

Management People of Adaptive Biotechnologies

Name	Title
Mr. Chad M. Robins M.B.A.	Co-Founder, CEO & Chairman
Ms. Julie Rubinstein	President & COO
Dr. Harlan S. Robins Ph.D.	Co-Founder & Chief Scientific Officer
Dr. Sharon Benzeno Ph.D.	Chief Commercial Officer of Immune Medicine
Mr. Christopher Carlson Ph.D.	Founder
Mr. Kyle Piskel	VP, CFO & Principal Accounting Officer
Ms. Karina Calzadilla	Vice President of Investor Relations
Mr. Francis T. Lo	Chief People Officer
Ms. Susan Bobulsky	Chief Commercial Officer of MRD
Ms. Mary Pat Lancelotta	Senior Vice President of MRD BioPharma

Important FAQs about investing in ADPT Stock from India :

What is Adaptive Biotechnologies share price today?

Adaptive Biotechnologies share price today stands at $7.36, Open: $7.44 ; Previous Close: $7.36 ; High: $7.50 ; Low: $7.22 ; 52 Week High: $9.01 ; 52 Week Low: $2.56.

The stock opens at $7.44, after a previous close of $7.36. The stock reached a daily high of $7.50 and a low of $7.22, with a 52-week high of $9.01 and a 52-week low of $2.56.

Can Indians buy Adaptive Biotechnologies shares?

Yes, Indians can invest in the Adaptive Biotechnologies (ADPT) from India.

With INDmoney, you can buy Adaptive Biotechnologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Adaptive Biotechnologies at zero transaction cost.

How can I buy Adaptive Biotechnologies shares from India?

It is very easy to buy Adaptive Biotechnologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Adaptive Biotechnologies (ADPT) be purchased?

Yes, you can buy fractional shares of Adaptive Biotechnologies with INDmoney app.

What are the documents required to start investing in Adaptive Biotechnologies stocks?

To start investing in Adaptive Biotechnologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.